Canopy Growth Corporation(WEED-T)
TSX

Today's Change
Real-Time Last Update
Day Low1.00
Day High1.07
Open:1.06
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Business Wire
Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
Business Wire
Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
Business Wire
Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
Baystreet
Stocks in play: Canopy Growth Corporation
Business Wire
Canopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special Meeting
Business Wire
Canopy Growth Expands European Medical Cannabis Supply Into the UK
Business Wire
Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline
Business Wire
Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and Formulations
Business Wire
Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
Business Wire
Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
Baystreet
Stocks in play: Canopy Growth Corporation
Business Wire
Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
Baystreet
Stocks in play: Canopy Growth Corporation
Business Wire
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
Business Wire
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
Newsfile
Upcoming Meeting Dates - July 13, 2026
SYNDTGAM
Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on Nov. 11, 2022.
SYNDTGAM
Small caps to watch: MDA acquisition, Ag Growth strategic review update and cannabis company earnings
A group of men walks past a building in Toronto that used to house the Toronto Stock Exchange on Thursday, Aug. 18 2011
Business Wire
Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis

Profile

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Market data provided by Barchart. Exchange delay details and data provider terms here. Information may be delayed, is provided 'as is' and is solely for informational purposes, and not for trading, investment or advice.